Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Andorra

Andorra: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 96.0% in 2025. ◆ Volatile

Latest (2025)
96.0%
Change on year
down 1.0%
World rank
26th
of 194 countries
All-time high
97.0%
in 2019
All-time low
0.0%
in 2000
Years of data
26
2000–2025

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra, 2000–2025

0204060801002000201220252000: 02001: 02002: 02003: 02004: 02005: 02006: 02007: 802008: 862009: 822010: 862011: 822012: 892013: 912014: 902015: 882016: 902017: 942018: 952019: 972020: 932021: 972022: 962023: 962024: 972025: 96

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra is 96.0%, measured in 2025.

That represents a change of down 1.0% on the previous year and up 9.1% over ten years.

Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra peaked at 97.0% in 2019 and was at its lowest, 0.0%, in 2000.

That places Andorra 26th out of 194 countries with data for 2025, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra, year by year

Annual values for Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC) in Andorra, 2000 to 2025.
Year Value Change
2000 0.0% —
2001 0.0% —
2002 0.0% —
2003 0.0% —
2004 0.0% —
2005 0.0% —
2006 0.0% —
2007 80.0% —
2008 86.0% +7.5%
2009 82.0% -4.7%
2010 86.0% +4.9%
2011 82.0% -4.7%
2012 89.0% +8.5%
2013 91.0% +2.2%
2014 90.0% -1.1%
2015 88.0% -2.2%
2016 90.0% +2.3%
2017 94.0% +4.4%
2018 95.0% +1.1%
2019 97.0% +2.1%
2020 93.0% -4.1%
2021 97.0% +4.3%
2022 96.0% -1.0%
2023 96.0% +0.0%
2024 97.0% +1.0%
2025 96.0% -1.0%

Andorra compared with similar countries

  • Andorra's 96.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
  • Andorra's 96.0% is above the median for Europe & Central Asia, which is 90.0%, 1.1× the median. (51 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 24.8% 0.0% 86.0% 10
2010s 90.2% 82.0% 97.0% 10
2020s 95.8% 93.0% 97.0% 6

Countries ranked near Andorra

  1. 23 Guyana 97.0% compare
  2. 23 Seychelles 97.0% compare
  3. 23 Tunisia 97.0% compare
  4. 26 Trinidad and Tobago 96.0% compare
  5. 26 Egypt 96.0% compare
  6. 29 India 95.0% compare
  7. 29 Uruguay 95.0% compare
  8. 29 Norway 95.0% compare
  9. 29 Mongolia 95.0% compare
  10. 29 Japan 95.0% compare
  11. 29 Vietnam 95.0% compare
  12. 29 South Korea 95.0% compare
  13. 29 Portugal 95.0% compare
  14. 29 Russia 95.0% compare
  15. 29 Armenia 95.0% compare
  16. 29 Tuvalu 95.0% compare
  17. 29 Sri Lanka 95.0% compare
  18. 29 United States 95.0% compare
  19. 29 Nicaragua 95.0% compare

See the full ranking of 207 places →

More health data for Andorra

All data for Andorra →

Frequently asked questions

What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra?
Measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Andorra?
The highest recorded value was 97.0% in 2019.
What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Andorra?
The lowest recorded value was 0.0% in 2000.
How does Andorra rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
Andorra ranks 26th out of 194 countries with data for 2025.
Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Andorra?
Over the last ten years it is up 9.1%. The long-run trend across the full record is volatile.
Where does this Andorra data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/andorra/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/andorra/">Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra</a> — Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 5,363 data points, 2000–2025
Last refreshed